Elevance Health (ELV) Gross Margin (2009 - 2026)

Elevance Health (ELV) has reported Gross Margin for 18 consecutive years, with 26.65% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin rose 39.0% year-over-year to 26.65% in Q2 2026; TTM through Jun 2026 was 25.99%, a 83.0% decrease from a year earlier, with the FY2025 full-year figure at 25.56%, down 237.0% from the prior year.
• Gross Margin was 26.65% for Q2 2026 at Elevance Health, down from 29.03% in the prior quarter.
• Over five years, Gross Margin peaked at 30.34% in Q2 2024 and troughed at 23.48% in Q4 2025.
• A 5-year average of 26.76% and a median of 26.59% in 2026 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin soared 270 bps in 2024 and slumped 408 bps in 2025, its largest moves.
• Over 5 years, Gross Margin stood at 24.38% in 2022, then gained by 9 bps to 26.53% in 2023, then declined by 1 bps to 26.28% in 2024, then decreased by 11 bps to 23.48% in 2025, then grew by 13 bps to 26.65% in 2026.
• The last three Gross Margin figures came in at 26.65% (Q2 2026), 29.03% (Q1 2026), and 23.48% (Q4 2025), per Business Quant data.